Clinical Consultant: Professor David Matthews
David is Professor of Diabetic Medicine at the University of Oxford and Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism and divides his time between research, teaching and clinical care. He advises the company on clinical matters including the design and execution of the clinical trials to test the safety and efficacy of needle-free delivery of glucagon with the Particle Therapeutics Device.
Formulation Consultant: Professor Geoffrey Lee
Geoffrey is Professor and Head of the Department of Pharmaceutics at Friedrich-Alexander University, Erlangen, Germany. He advises the company on the formulation of concentrated glucagon particles and manufacturing processes.
